The evolving classification of renal cell neoplasia

Seminars in Diagnostic Pathology

Volumn 32, Issue 2, 2015, Pages 90-102

  Delahunt, Brett ^a   Srigley, John R ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Classification; Morphology; Renal adenoma; Renal cell carcinoma; Rochester Heidelberg; Vancouver

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; SUCCINATE DEHYDROGENASE;

ACQUIRED CYSTIC DISEASE ASSOCIATED RENAL CELL CARCINOMA; ANAPLASTIC LYMPHOMA KINASE RENAL CELL CARCINOMA; ANGIOLEIOMYOMATOUS STROMA RENAL CELL CARCINOMA; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLEAR CELL CARCINOMA; FOLLICULAR CARCINOMA; GENETIC ANALYSIS; HEREDITARY LEIOMYOMATOSIS RENAL CELL CARCINOMA SYNDROME ASSOCIATED RENAL CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; LEIOMYOMATOSIS; MICROPHTHALMIA TRANSCRIPTION FACTOR FAMILY TRANSLOCATION RENAL CELL CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SUCCINATE DEHYDROGENASE B MUTATION ASSOCIATED RENAL CELL CARCINOMA; THYROID LIKE FOLLICULAR RENAL CELL CARCINOMA; TUBEROUS SCLEROSIS COMPLEX COMPLEX ASSOCIATED RENAL CELL CARCINOMA; TUBULOCYSTIC RENAL CELL CARCINOMA; CLASSIFICATION; GENETICS; KIDNEY TUMOR; PATHOLOGY;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS;

EID: 84925059083     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2015.02.002     Document Type: Article

References (115)

1. Delahunt B., Thornton A. Renal cell carcinoma. A historical perspective. J Urol Pathol 1996, 4:31-49.
2. Delahunt B., Eble J.N. History of the development of the classification of renal cell carcinoma. Lab Clin N Am 2005, 25:231-246.
3. Rayer P. Cancer of the kidney. Treatise on Disease of the Kidney and the Alteration of Urinary Secretion. Book 3 1841, 675-718.
4. Cornil, Ranvier Special pathological histology. Manual of Pathological Histology 1886, 3:551. Smith Elder, London.
5. Grawitz P. The so-called lipoma of the kidney. Arch Path Anat Physiol Klin Med 1883, 93:39-63.
6. Grawitz P. The origin of kidney tumors from the adrenal gland. Arch Klin Chir 1884, 70:824-834.
7. Oberling C., Riviére M., Haguenan F. Ultrastructure of clear cell epitheliomas of the kidney (hypernephroma or Grawitz tumor) and its implications for the histogenesis of the tumours. Bull Cancer Assoc Franc 1959, 46:356-358.
8. Mancilla-Jimenez R., Stanley R.J., Blath R.A. Papillary renal cell carcinoma. A clinical, radiologic and pathologic study of 34 cases. Cancer 1976, 38:2469-2480.
9. Foot N.C., Papanicolaou G.N. Early renal carcinoma in situ: detected by means of smears of fixed urinary sediment. J Am Med Assoc 1969, 139:356-358.
10. Zippel L. Zur Kenntn˙is der Onkocyten. Virch Arch Pathol Anat Physiol Klin Med 1942, 308:368-382.
11. Thoenes W., Störkel S., Rumpelt H.-J., et al. Chromophobe cell renal cell carcinoma and its variants-a report on 32 cases. J Pathol 1988, 155:277-287.
12. Histological Typing of Kidney Tumours 1981, World Health Organization, Geneva. 1st ed. F.K. Mostofi, C.T. Davis (Eds.).
13. Thoenes W., Störkel S., Rumpelt H.-J., Moll R. Cytomorphological typing of renal cell carcinoma-a new approach. Eur Urol 1990, 18(suppl 2):6-9.
14. Mostofi F.K., Davis C.J., Sobin L.H., et al. Histological typing of kidney tumours. World Health Organization Histological Classification of Tumours 1998, Springer Verlag, Berlin. 2nd ed.
15. Kovacs G., Akhtar M., Beckwith J.B., et al. The Heidelberg classification of renal cell tumours. J Pathol 1997, 183:131-133.
16. Störkel S., Eble J.N., Adlakha K., et al. Classification of renal cell carcinoma. Cancer 1997, 80:987-989.
17. Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours 2004, IARC, Lyon. J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn (Eds.).
18. Eble J.N., Bonsib S.M. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma and cystic hamartoma of renal pelvis. Semin Diagn Pathol 1998, 15:2-20.
19. Delahunt B., Eble J.N., McCredie M.R.E., et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001, 32:590-595.
20. Argani P., Antonescu C.R., Illei P.B., et al. Primary renal neoplasms with ASPL/TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001, 159:179-192.
21. Fleitz J.M., Wootton-Gorges S.L., Wyatt-Ashmead J., et al. Renal cell carcinoma in long term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol 2003, 33:540-545.
22. Srigley J.R., Kapusta L., Reuter V., et al. Phenotypic, molecular and ultrastructural studies of a novel low-grade renal epithelial neoplasm possibly related to the loop of Henle. Mod Pathol 2002, 15:182.
23. Fine S.W., Argani P., DeMarzo A.M., et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma. Am J Surg Pathol 2006, 30:1554-1560.
24. Srigley J.R., Delahunt B., Eble J.N., et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013, 37:1469-1489.
25. Argani P., Olgac S., Tickoo S.K., et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007, 31:1149-1160.
26. Smith N.E., Illei P.B., Allaf M., et al. t(6; 11) renal cell carcinoma (RCC). Expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases. Am J Surg Pathol 2014, 38:604-614.
27. Argani P. MiT family translocation renal cell carcinoma. Semin Diagn Pathol, this issue.
28. Tickoo S.K., dePeralta-Venturina M.N., Harik L.R., et al. Spectrum of epithelial neoplasms in end-stage renal disease. An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006, 30:141-153.
29. Fushimi F., Taguchi K., Izumi H., et al. Peroxiredoxins, thioredoxin and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma. Virchow Arch 2013, 463:553-562.
30. Pan C.-C., Chen Y.-J., Chang L.-C., Chang Y.-H., Ho D.M. Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology 2009, 55:145-153.
31. Kuroda N., Tamura M., Hamaguchi N., et al. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol 2011, 15:462-466.
32. Sassa N., Hattori R., Tsuzuki T., et al. Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis?. Nephrol Dial Transplant 2011, 26:1677-1682.
33. Kuroda N., Shiotsu T., Kawada C., et al. Clear cell papillary renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol 2011, 15:282-285.
34. Karoda N., Ohe C., Mikami S., et al. Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol 2011, 26:1215-1218.
35. Enoki Y., Katoh G., Okabe H., Yanagisawa A. Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis. Histopathology 2010, 56:384-394.
36. Kuroda N., Shiotsu T., Hes O., et al. Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol 2010, 43:231-234.
37. Kuroda N., Yamashita M., Kakehi Y., et al. Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study. Med Mol Morphol 2011, 44:228-232.
38. Inoue T., Matsuura K., Yoshimoto T., et al. Genomic profiling of renal cell carcinoma in patients with end-stage renal disease. Cancer Sci 2012, 103:569-576.
39. Nouh M.A., Kuroda N., Yamashita M., et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int 2010, 105:620-627.
40. Zhou H., Zheng S., Truong, et al. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol 2014, 45:59-64.
41. Aydin H., Chen L., Cheng L., et al. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 2010, 34:1608-1621.
42. Mai K.T., Kohler D.M., Belanger E.C., et al. Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity. Pathology 2008, 40:481-486.
43. Williamson S.R., Eble J.N., Cheng L., Grignon D.J. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol 2013, 26:697-708.
44. Cui C., Ziober A., Bing Z. Expression of parafibromin in clear cell papillary renal cell carcinoma. Appl Immunohistochem Mol Morphol 2013, 21:322-325.
45. Pramick M., Ziober A., Bing Z. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics. Ann Diagn Pathol 2013, 17:437-440.
46. Gobbo S., Eble J.N., Grignon D.J., et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008, 32:1239-1245.
47. Adam J., Coururier J., Molinie V., Vieillefond A., Sibony M. Clear cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and comprehensive genomic hybridization array study of seven cases. Histopathology 2011, 58:1064-1071.
48. Rohan S.W.M., Xaio Y., Liang Y., et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 2011, 24:1207-1220.
49. Lawrie C.H., Larrea E., Larrinaga G., et al. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes. J Pathol 2014, 232:32-42.
50. Reed W.B., Walker R., Horowitz R. Cutaneous leiomyomata with uterine leiomyomata. Acta Dermato-Venereol 1973, 53:409-416.
51. Launonen V., Vierimaa O., Kiuru M., et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 2001, 98:3387-3392.
52. Toro J.R., Nickerson M.L., Wei M.H., et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003, 12:1241-1252.
53. Linehan W.M., Rouault T.A. Molecular Pathways: fumarate hydratase-deficient kidney cancer-targeting the Warburg effect in cancer. Clin Can Res 2013, 19:3345-3352.
54. Sanz-Ortega J., Vocke C., Stratton P., Linehan W.M., Merino M.J. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol 2013, 37:74-80.
55. Schuh B., Ricketts C.J., Vocke C.D., et al. Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol 2013, 189:430-435.
56. Chen Y.-B., Brannon A.R., Toubaji A., et al. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer. Recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol 2014, 38:627-637.
57. Merino M.J., Torres-Cabala C., Pinto P.A., et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 2007, 31:1578-1585.
58. Udager A.M., Alva A., Chen Y.-B., et al. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC). A rapid autopsy report of metastatic renal cell carcinoma. Am J Surg Pathol 2014, 38:567-577.
59. van Spaendonck-Zwarts K.Y., Badeloe S., Oosting S.F., et al. Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance. Fam Cancer 2012, 11:123-129.
60. Raymond V.M., Herron C.M., Giordano T.J., Gruber S.B. Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome. Fam Cancer 2012, 11:115-121.
61. Smit D.L., Mensenkamp A.R., Badeloe S., et al. Hereditary leiomyomatosis and renal cell cancer in families referred for fumerate hydratase germline mutation analysis. Clin Genet 2011, 79:49-59.
62. Azoulay S., Viellefond A., Paraf F., et al. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch 2007, 451:905-909.
63. Yang X.J., Zhou M., Hes O., et al. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol 2008, 32:177-187.
64. Amin M.B., MacLennan G.T., Gupta R., et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 2009, 33:384-392.
65. Zhou M., Yang X.J., Lopez J.I., et al. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol 2009, 33:1840-1849.
66. Hora M., Ürge T., Eret V., et al. Tubulocystic renal carcinoma: a clinical perspective. World J Urol 2011, 29:349-354.
67. Alexiev B.A., Drachenberg C.B. Tubulocystic carcinoma of the kidney: a histologic immunohistochemical, and ultrastructural study. Virchows Arch 2013, 462:575-581.
68. Teramoto S., Niwakawa M., Muraoka K., et al. Tubulocystic carcinoma of the kidney. Jap J Urol 2011, 102:696-700.
69. Brennan C., Srigley J.R., Whelan C., Cooper J., Delahunt B. Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying concept. Anticancer Res 2010, 30:641-644.
70. Deshmukh M., Shet T., Bakshi G., Desai S. Tubulocystic carcinoma of kidney associated with papillary renal cell carcinoma. Indian J Pathol Microbiol 2011, 54:127-130.
71. Al-Hussain T.O., Cheng L., Zhang S., Epstein J.I. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis. Human Pathol 2013, 44:1406-1411.
72. Zhang S.H., Shi S.F., Huang S.F., et al. Clinical and pathologic features of tubulocystic kidney. Chin J Pathol 2012, 41:543-546.
73. Quiroga-Garza G., Pina-Oviedo S., Cuevas-Ocampo K., et al. Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression. Diagn Pathol 2012, 7:21.
74. Steiner P., Hora M., Stehlik J., et al. Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases. Virchows Arch 2013, 462:183-192.
75. Osunkoya A.O., Young A.N., Wang W., et al. Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. Am J Surg Pathol 2009, 33:1103-1106.
76. Mego M., Sycova-Mila Z., Rejlekova K., et al. Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report. Ann Oncol 2008, 19:1655-1656.
77. Bhullar J.S., Thamboo T., Esuvaranathan K. Unique case of tubulocystic carcinoma of the kidney with sarcomatoid features: a new entry. Urology 2011, 78:1071-1072.
78. Jung S.J., Chung J.I., Park S.H., Ayala A.G., Ro J.Y. Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis. Am J Surg Pathol 2006, 30:411-415.
79. Sterlacci W., Verdorfer I., Gabriel M., Mikuz G. Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic, and scintigraphic studies. Virchows Arch 2008, 452:91-95.
80. Amin M.B., Gupta R., Ondrej H., et al. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol 2009, 33:393-400.
81. Dhillon J., Tannir N.M., Matin S.F., et al. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol 2011, 42:146-150.
82. Alessandrini L., Fassan M., Gardiman M.P., et al. Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. Virchows Arch 2012, 461:345-350.
83. Malde S., Sheikh I., Woodman I., et al. Primary thyroid-like follicular renal cell carcinoma: an emerging entity. Case Rep Pathol 2013, 2013, 5 (Articale ID 687427).
84. Volavsek M., Strojan-Flezar M., Mikuz G. Thyroid-like follicular carcinoma of the kidney in a patient with nephrolithiasis and polycystic kidney disease: a case report. Diagn Pathol 2013, 8:108.
85. Chougule A., Bal A., Das A., Nayak B. Thyroid-like follicular renal cell carcinoma: an emerging morphological variant. Pathology 2014, 46:657-659.
86. Khoja H.A., Almutawa A., Binmahfooz A., et al. Papillary thyroid carcinoma-like tumor of the kidney: a case report. Int J Surg Pathol 2012, 20:411-415.
87. Ohe C., Kuroda N., Pan C.C., et al. A unique renal cell carcinoma with features of papillary renal cell carcinoma and thyroid-like carcinoma: a morphological, immunohistochemical and genetic study. Histopathology 2010, 57:494-497.
88. Fadare O., Lam S., Rubin C., Renshaw I.L., Nerby C.L. Papillary renal cell carcinoma with diffuse clear cells and thyroid-like macrofollicular areas. Ann Diagn Pathol 2010, 14:284-289.
89. Debelenko L.V., Raimondi S.C., Daw N., et al. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 2011, 24:430-442.
90. Marino-Enriquez A., Ou W.B., Weldon C.B., Fletcher J.A., Perez-Atayde A.R. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Gene Chromosome Cancer 2011, 50:146-153.
91. Smith N.E., Deyrup A.T., Marino-Enriques A., et al. VCL-ALK renal cell carcinoma in children with sickle-cell trait. Am J Surg Pathol 2014, 38:858-863.
92. Sugawara E., Togashi Y., Kuroda N., et al. Identification of anaplastic lymphoma kinase fusions in renal cancer. Cancer 2012, 44:27-36.
93. Sukov W.R., Hodge J.C., Lohse C.M., et al. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol 2012, 25:1516-1525.
94. Ryan C., Mayer N., Cunningham J., et al. Increased ALK1 copy number and renal cell carcinoma-a case report. Virchows Arch 2014, 464:241-245.
95. Davis C.J., Mostofi F.K., Sesterhenn I.A. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 1995, 19:1-11.
96. Amin M.B., Smith S.C., Agaimy A., et al. Collecting duct carcinoma versus renal medullary carcinoma. Am J Surg Pathol 2014, 38:871-874.
97. Ricketts C., Woodward E.R., Killick P., et al. Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 2008, 100:1260-1262.
98. Gill A., Pachter N.S., Chou A., et al. Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol 2011, 35:1578-1585.
99. Ricketts C.J., Shuch B., Vocke C.D., et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol 2012, 188:2063-2071.
100. Malinoc A., Sullivan M., Wiech T., et al. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocr Relat Cancer 2012, 19:283-290.
101. Williamson S.R., Eble J.N., Amin M.B., et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol 2015, 28:80-94.
102. Tuthill M., Barod R., Pyle L., et al. A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib. BMJ Case Rep 2009, [Epub 2009 Feb.16]. 10.1136/bcr.08.2008.0732.
103. Przybycin C.G., Magi-Galluzzi C., McKenney J.K. Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol 2013, 20:245-263.
104. Merino M.J. What is new in renal pathology?. Int J Surg Pathol 2010, 18:98S-100S.
105. Kuhn E., De Anda J., Manoma S., et al. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: report of 5 cases and review of the literature. Am J Surg Pathol 2006, 30:1372-1381.
106. Shannon B.A., Cohen R.J., Segal A., et al. Clear cell renal cell carcinoma with smooth muscle stroma. Hum Pathol 2009, 40:425-429.
107. Michal M., Hes O., Havlicek F. Benign renal angiomyoadenomatous tumor: a previously unreported renal tumor. Ann Diagn Pathol 2000, 4:311-315.
108. Michal M., Hes O., Nemcova J., et al. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch 2009, 454:89-99.
109. Guo J., Tretiakova M.S., Troxell M.L., et al. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol 2014, 38:1457-1467.
110. Schreiner A., Daneshmand S., Bayne A., et al. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int J Surg Pathol 2010, 18:409-418.
111. Yang P., Cornejo K.M., Sadow P.M., et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol 2014, 38:896-909.
112. Williamson S.R., Cheng L., Eble J.N., et al. Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity. Mod Pathol 2015, 28:279-294.
113. Petersson F., Grossmann P., Hora M., et al. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma. Hum Pathol 2013, 44:1412-1420.
114. Corominas Cishek A., Gonzalez M., Caamano V., Andueza E., Cerda N., Lopez J.J. Biphasic alveolo-squamoid renal carcinoma (BASRC): light and immunohistochemical study of 3 cases. Virchows Arch 2014, 465(suppl 1):S157.
115. Petersson F., Bulimbasic S., Hes O., et al. Biphasic alvelosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma. Ann Diagn Pathol 2012, 16:459.